7Baggers
 Wolfe Research initiates Exelixis stock with Peerperform rating  Investing.com India Mon, 17 Nov 2025 22:24:10 GMT
 Former Exelixis GC Named Legal Chief At Cytokinetics  Law360 Mon, 17 Nov 2025 14:30:00 GMT
 Exelixis Stock Soars on Strong Earnings and Major Buyback Plan  AD HOC NEWS Mon, 17 Nov 2025 13:54:04 GMT
 This Insider Has Just Sold Shares In Exelixis  富途牛牛 Sun, 16 Nov 2025 13:38:53 GMT
 rbc capital keeps their hold rating on exelixis (exel)  The Globe and Mail Sat, 15 Nov 2025 13:56:18 GMT
 here's why exelixis (exel) is a strong momentum stock  sharewise.com Fri, 14 Nov 2025 09:02:00 GMT
 Exelixis director Papadopoulos sells $4.35 million in stock By Investing.com  Investing.com Nigeria Fri, 14 Nov 2025 05:36:22 GMT
 exelixis director beckerle sells $1m+ in shares by investing.com  Investing.com Australia Fri, 14 Nov 2025 05:21:23 GMT
 Director Stelios Papadopoulos Sells 100,000 Shares of Exelixis I  GuruFocus Fri, 14 Nov 2025 02:05:37 GMT
 aftab dana, exelixis evp, r&d, sells $2.05 million in stock by investing.com  Investing.com Australia Fri, 14 Nov 2025 01:24:35 GMT
 Exelixis director Beckerle sells $1m+ in shares  Investing.com India Fri, 14 Nov 2025 01:02:10 GMT
 Exelixis(EXEL.US) Director Sells US$4.36 Million in Common Stock  富途牛牛 Fri, 14 Nov 2025 00:14:21 GMT
 Here's Why Exelixis (EXEL) is a Strong Momentum Stock  Yahoo Finance Thu, 13 Nov 2025 14:50:03 GMT
 why exelixis (exel) is a top growth stock for the long-term  sharewise.com Wed, 12 Nov 2025 08:01:32 GMT
 Exelixis Hits 80-Plus Relative Strength Rating Benchmark  Investor's Business Daily Wed, 12 Nov 2025 08:00:00 GMT
 exelixis at guggenheim conference: strategic growth in oncology by investing.com  Investing.com Australia Tue, 11 Nov 2025 17:29:04 GMT
 why exelixis (exel) is a top growth stock for the long-term  Yahoo Finance Tue, 11 Nov 2025 14:45:03 GMT
 Exelixis at Guggenheim Conference: Strategic Growth in Oncology  Investing.com Mon, 10 Nov 2025 17:14:08 GMT
 Biopharmaceutical Co. Exelixis' GC Steps Down  Law360 Sat, 08 Nov 2025 01:45:00 GMT
 exelixis, inc. announces executive changes, effective november 7, 2025  MarketScreener Fri, 07 Nov 2025 21:07:00 GMT
 exelixis price target raised to $45 from $44 at morgan stanley  TipRanks Fri, 07 Nov 2025 17:14:58 GMT
 ubs raises price target for exelixis (exel) to $40.00 | exel sto  GuruFocus Thu, 06 Nov 2025 18:04:57 GMT
 exelixis, inc. (nasdaq:exel) q3 2025 earnings call transcript  Insider Monkey Thu, 06 Nov 2025 13:25:03 GMT
 Exelixis Sees Its Composite Rating Rise To 97  Investor's Business Daily Thu, 06 Nov 2025 08:00:00 GMT
 exelixis announces $750 million stock repurchase program  The Globe and Mail Thu, 06 Nov 2025 05:59:32 GMT
 how exelixis inc. (exel) affects rotational strategy timing  news.stocktradersdaily.com Thu, 06 Nov 2025 02:36:02 GMT
 exelixis’ earnings call: strong growth amid challenges  TipRanks Thu, 06 Nov 2025 00:48:24 GMT
 exel: td cowen raises price target to $51.00, maintains buy rati  GuruFocus Wed, 05 Nov 2025 19:34:41 GMT
 exelixis (exel) receives analyst rating update from morgan stanl  GuruFocus Wed, 05 Nov 2025 18:44:34 GMT
 exelixis price target raised to $43 from $41 at stifel  TipRanks Wed, 05 Nov 2025 18:21:25 GMT
 exelixis price target raised to $49 from $46 at h.c. wainwright  TipRanks Wed, 05 Nov 2025 17:36:07 GMT
 exel: hc wainwright & co. raises price target, maintains buy rat  GuruFocus Wed, 05 Nov 2025 17:23:20 GMT
 exel tops q3 earnings estimates, cabometyx fuels product sales  Zacks Investment Research Wed, 05 Nov 2025 15:01:23 GMT
 exelixis price target raised to $51 from $44 at td cowen  TipRanks Wed, 05 Nov 2025 14:25:25 GMT
 exelixis reports q3 adjusted eps 81c, consensus 67c  MSN Wed, 05 Nov 2025 13:34:42 GMT
 exelixis q3 2025 earnings call transcript  MarketBeat Wed, 05 Nov 2025 11:50:59 GMT
 exelixis stock steady as oppenheimer maintains perform rating  Investing.com Wed, 05 Nov 2025 08:00:00 GMT
 exelixis (exel): is there more value left after recent growth?  simplywall.st Wed, 05 Nov 2025 07:45:24 GMT

Exelixis, Inc
(NASDAQ:EXEL) 

EXEL stock logo

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who receiv...

Founded: 1994
Full Time Employees: 617
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends